A new CDC report on data collected by the Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy, indicates that medication for opioid use disorder is more often given to individuals who are White, older, and have private insurance.
The brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.
Inhaled corticosteroids were observed to be associated with increases in rates of pneumonia and tuberculosis, according to a recent study.
A new study investigates whether GPT-4 can provide more in-depth analysis than medical professionals.
WHO ends COVID-19 public health emergency, privacy concerns around mental health apps, and astronomical interest with medical credit cards.
A recent clinical trial showed positive results from the selective neurokinin-1,3 receptor antagonist elinzanetant (Bayer) against menopausal vasomotor symptoms.
Despite having a highly differentiated clinical value proposition compared to branded, twice-nightly oxybates, Avadel is pricing Lumryz at $64.67 per gram or around $177,034 annually, which is on par with twice-nightly oxybate products that require chronic, middle-of-the-night awakening.
Lawmakers take on harm reduction, in-flight medical emergency kits are under review, and a new Alzheimer drug shows promise.
According to a recent study, the association between employment status and contraceptive use observed in a period before the Affordable Care Act (ACA) was not found after the ACA ended.
Both Democrats and Republicans voted to bring back the act that attempts to improve use of antibiotics
Though the Omicron variant caused the most symptoms in pediatric patients, there were no differences in adverse outcomes by COVID-19 variant.
The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.
How much does education about the specific risks of smoking assist in smoking cessation?
The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.
A recent study found that Medicare patients used low-benefit options more frequently than high-benefit options.
The NexGard COMBO topical solution from Boehringer Ingelheim helps protect cats from tapeworms and other intestinal parasites like fleas, ticks, and heartworms.
According to a recent study, pregnant women infected with COVID-19 experienced significant maternal mortality during pregnancy, with worse outcomes during the second wave of the pandemic compared to the first.
Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.
IBS in pediatric patients has not been studied much, but new data reveals a possible treatment.
STAQ, a 503B outsourcing facility, started making desmopressin nasal spray after Ferring Pharmaceuticals suspended production nearly three years ago.
Combining the two drugs appears more likely to reduce risk of early COVID-19 symptoms worsening than taking either one on its own.
The FDA is hoping these warnings are a positive step in what will be an extremely long process of ending opioid related deaths.
Post-COVID-19 conditions were more common in unvaccinated children than in children who had received at least 1 dose of a COVID-19 vaccine.
The Senate Finance Committee recently released a framework for legislation, and the leaders of the “big three” PBMs are scheduled to be witnesses at another committee's hearing regarding insulin prices on May 10.
A study in Scotland found that multiple successive changes from originator infliximab to biosimilars effective and safe for patients with irritable bowel disease (IBD), irrespective of the number of switches (single, double, and triple).
A recent review studied the increased requests for telemedicine abortion care and decreased in-person visits to abortion clinics.
The expansion from Express Scripts offers increased reimbursement opportunities and creates an Independent Pharmacy Advisory Committee to expand the role of rural, suburban and urban pharmacies in the healthcare system.
RizaFilm is a different formulation of rizatriptan that has been changed into a film, meant to be taken orally and absorbed in mouth.
This comes after a district court in Texas ruled to keep Mifepristone available, but with heavy restrictions.
Data was presented at the 44th National Association of Pediatric Nurse Practitioners Conference regarding the effectiveness of vaccines and antivirals in preventing life threatening conditions.
